- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
Wockhardt Limited — Updates, 03-11-2025: Press Release
03-11-2025 | 03:35 pm
03-11-2025 | 03:35 pm
Wockhardt Q2FY26 PBT turned positive at ₹91 Cr, with revenue at ₹782 Cr and EBITDA up 58% QoQ to ₹160 Cr. Key progress includes US FDA submission for novel antibiotic Zaynich, a first for an Indian firm, and strong 42% growth in biotech operations.
No comments yet. Be the first to comment!